Yuyu Pharma Inc - Asset Resilience Ratio

Latest as of March 2025: 1.74%

Yuyu Pharma Inc (000227) has an Asset Resilience Ratio of 1.74% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Yuyu Pharma Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩3.65 Billion
≈ $2.47 Million USD Cash + Short-term Investments

Total Assets

₩209.62 Billion
≈ $142.06 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Yuyu Pharma Inc's Asset Resilience Ratio has changed over time. See Yuyu Pharma Inc net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Yuyu Pharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Yuyu Pharma Inc (000227) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩3.65 Billion 1.74%
Total Liquid Assets ₩3.65 Billion 1.74%

Asset Resilience Insights

  • Limited Liquidity: Yuyu Pharma Inc maintains only 1.74% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Yuyu Pharma Inc Industry Peers by Asset Resilience Ratio

Compare Yuyu Pharma Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Yuyu Pharma Inc (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Yuyu Pharma Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.39% ₩817.27 Million
≈ $553.85K
₩207.69 Billion
≈ $140.75 Million
-0.49pp
2023-12-31 0.88% ₩1.75 Billion
≈ $1.19 Million
₩198.21 Billion
≈ $134.33 Million
-1.65pp
2022-12-31 2.53% ₩4.94 Billion
≈ $3.35 Million
₩195.21 Billion
≈ $132.29 Million
+2.41pp
2020-12-31 0.12% ₩180.00 Million
≈ $121.98K
₩154.90 Billion
≈ $104.97 Million
-0.29pp
2018-12-31 0.40% ₩545.95 Million
≈ $369.98K
₩135.23 Billion
≈ $91.64 Million
-0.01pp
2017-12-31 0.41% ₩500.00 Million
≈ $338.84K
₩121.49 Billion
≈ $82.33 Million
-0.05pp
2016-12-31 0.46% ₩509.59 Million
≈ $345.34K
₩111.30 Billion
≈ $75.43 Million
-0.02pp
2015-12-31 0.48% ₩500.00 Million
≈ $338.84K
₩104.33 Billion
≈ $70.70 Million
-0.06pp
2014-12-31 0.54% ₩550.00 Million
≈ $372.73K
₩101.40 Billion
≈ $68.72 Million
--
pp = percentage points

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$42.93 Million
₩63.34 Billion KRW
Market Cap Rank
#22443 Global
#1518 in Korea
Share Price
₩10810.00
Change (1 day)
-0.37%
52-Week Range
₩9900.00 - ₩11670.00
All Time High
₩56262.57
About

Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more